BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38188927)

  • 1. Intraductal radiofrequency ablation plus biliary stent versus stent alone for malignant biliary obstruction: a systematic review and meta-analysis.
    de Oliveira Veras M; de Moura DTH; McCarty TR; de Oliveira GHP; Gomes RSA; Landim DL; Nunes FG; Franzini TAP; Lera Dos Santos ME; Bernardo WM; de Moura EGH
    Endosc Int Open; 2024 Jan; 12(1):E23-E33. PubMed ID: 38188927
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis.
    Sofi AA; Khan MA; Das A; Sachdev M; Khuder S; Nawras A; Lee W
    Gastrointest Endosc; 2018 Apr; 87(4):944-951.e1. PubMed ID: 29108980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Benefit of Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction: A Systematic Review with Meta-Analysis.
    Cha BH; Jang MJ; Lee SH
    Clin Endosc; 2021 Jan; 54(1):100-106. PubMed ID: 33445841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Radiofrequency Ablation Along With Stenting Versus Stenting Alone for Biliary Tree Drainage in Patients With Malignant Biliary Strictures: A Systemic Review and Meta-analysis.
    Hayat U; Ashfaq MZ; Haseeb M; Farhan ML; Kamal MU; Talib KA; Khan HMA; Siddiqui AA
    J Clin Gastroenterol; 2024 Mar; 58(3):297-306. PubMed ID: 37039475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials.
    Song S; Jin H; Cheng Q; Gong S; Lv K; Lei T; Tian H; Li X; Lei C; Yang W; Yang K; Guo T
    Surg Endosc; 2022 Aug; 36(8):5559-5570. PubMed ID: 35296949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis.
    Tarar ZI; Farooq U; Gandhi M; Ghous G; Saleem S; Kamal F; Imam Z; Jamil L
    Eur J Gastroenterol Hepatol; 2023 Jun; 35(6):646-653. PubMed ID: 37129575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of temperature-controlled endobiliary radiofrequency ablation for inoperable hilar cholangiocarcinoma: A propensity score-matched analysis.
    Shin IS; Moon JH; Lee YN; Myeong JH; Lee TH; Yang JK; Cho YD; Park SH
    Endosc Int Open; 2024 Apr; 12(4):E535-E544. PubMed ID: 38720905
    [No Abstract]   [Full Text] [Related]  

  • 8. The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Balducci D; Montori M; Martini F; Valvano M; De Blasio F; Argenziano ME; Tarantino G; Benedetti A; Bendia E; Marzioni M; Maroni L
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Malignant Biliary Strictures: A Systematic Review and Meta-analysis.
    Khizar H; Hu Y; Wu Y; Ali K; Iqbal J; Zulqarnain M; Yang J
    J Clin Gastroenterol; 2023 Apr; 57(4):335-345. PubMed ID: 36628465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for treatment of malignant biliary obstruction.
    Yu T; Zhang W; Li C; Wang C; Gong G; Wang L; Li G; Chen Y; Wang X
    Abdom Radiol (NY); 2020 Nov; 45(11):3690-3697. PubMed ID: 32277241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience.
    Cui W; Fan W; Lu M; Zhang Y; Yao W; Li J; Wang Y
    BMC Cancer; 2017 Apr; 17(1):288. PubMed ID: 28438130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of temperature-controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: A pilot multicenter randomized comparative trial.
    Kang H; Han SY; Cho JH; Kim EJ; Kim DU; Yang JK; Jeon S; Park G; Lee TH
    J Hepatobiliary Pancreat Sci; 2022 Apr; 29(4):469-478. PubMed ID: 34800357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial.
    Jarosova J; Zarivnijova L; Cibulkova I; Mares J; Macinga P; Hujova A; Falt P; Urban O; Hajer J; Spicak J; Hucl T
    Gut; 2023 Nov; 72(12):2286-2293. PubMed ID: 37652677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction.
    Cui W; Wang Y; Fan W; Lu M; Zhang Y; Yao W; Li J
    Int J Hyperthermia; 2017 Nov; 33(7):853-861. PubMed ID: 28540797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma-A Systematic Review and Meta-Analysis.
    de Jong DM; Fritzsche JA; Audhoe AS; Yi SSL; Bruno MJ; Voermans RP; van Driel LMJW
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of local palliative therapeutics for unresectable malignant biliary obstruction: a Bayesian network meta-analysis.
    Song S; Gong S; Lei T; Tian H; Lu T; Lei C; Jin H; Yang W; Yang K; Guo T
    Expert Rev Gastroenterol Hepatol; 2022 Jun; 16(6):555-567. PubMed ID: 35639826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction.
    Oh D; Chong J; Song TJ; Park DH; Lee SS; Seo DW; Lee SK; Kim MH
    J Gastroenterol Hepatol; 2022 Nov; 37(11):2083-2090. PubMed ID: 35869749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of intraductal RFA in patients with malignant biliary obstruction.
    Han SY; Kim DU; Kang DH; Baek DH; Lee TH; Cho JH
    Medicine (Baltimore); 2020 Aug; 99(33):e21724. PubMed ID: 32872053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-stent radiofrequency ablation with uncovered metal stent placement for tumor ingrowth/overgrowth causing self-expandable metal stent occlusion in distal malignant biliary obstruction: multicenter propensity score-matched study.
    Park N; Jung MK; Kim EJ; Paik WH; Cho JH
    Gastrointest Endosc; 2023 Apr; 97(4):694-703.e2. PubMed ID: 36460085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a randomized controlled multicenter trial.
    Albers D; Schmidt A; Schiemer M; Caca K; Wannhoff A; Sauer P; Wiesweg M; Schumacher B; Dechene A
    Gastrointest Endosc; 2022 Dec; 96(6):970-979. PubMed ID: 35667389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.